HRQoL trajectories of patients with aggressive B-cell lymphomas treated with CAR T-cell therapy
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-01-14
Просмотров: 7
Описание:
Fabio Efficace, PhD, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy, discusses the results of a prospective observational study examining the health-related quality of life (HRQoL) trajectories of patients with aggressive B-cell lymphomas treated with CAR T-cell therapy. He highlights significant impairments in HRQoL during the first month post-infusion, followed by substantial improvements observed up to 12 months in key health domains, such as pain and fatigue. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![GOSPODARKA WOJENNA ROSJI - CZY PUTIN JUŻ PRODUKUJE CZOŁGI ZAMIAST LODÓWEK [BOJKE]](https://image.4k-video.ru/id-video/g2t5npoRfBA)
